SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: VLAD who wrote (18970)2/20/1999 11:05:00 PM
From: 777 Captain  Respond to of 23519
 
Thanks VLAD. The fact that the company the size of Astra even mentioned Muse by name surprised me. I'm banking on the fact that LW is waiting to do a deal with them. If I'm wrong, it won't be the first time. Regards.



To: VLAD who wrote (18970)2/22/1999 2:16:00 PM
From: DaiS  Read Replies (1) | Respond to of 23519
 
Vlad,

Yes I think the Astra results are very promising. Big share of market compared with US. Viagra impact only caused 17% decline in revenue Q3 to Q4, but now muse recovered to former levels.

I agree with your population figures and inferences about prospective muse specification and it's profitability in Europe.

DaiS


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News